Literature DB >> 26321241

The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration.

H Sun1, E S Calipari1, T J R Beveridge1, S R Jones1, R Chen2.   

Abstract

Persistent neuroadaptations following chronic psychostimulant exposure include reduced striatal dopamine D2 receptor (D2R) levels. The signaling of D2Rs is initiated by Gαi/o proteins and terminated by regulator of G protein signaling (RGS) proteins. The purpose of this study is to examine the association of the drug taking behavior and gene expression profile of D2/D3Rs, and their associated signaling proteins in the ventral tegmental area (VTA) and nucleus accumbens (NAc) using a rodent model of amphetamine (AMPH) self-administration. Rats were allowed to self-administer AMPH (0.187 mg/kg/infusion for a maximum of 40 injections in 6h daily sessions) for 5 days during which rats showed an escalated rate of AMPH intake across days. AMPH self-administration induced profound brain region-dependent alterations of the targeted genes. There was a positive correlation of the messenger ribonucleic acid (mRNA) levels of RGS10 between the VTA and the NAc in the control animals, which was abolished by AMPH self-administration. AMPH self-administration also produced a negative correlation of the mRNA levels of RGS7 and RGS19 between the two brain regions, which was not present in the control group. Furthermore, AMPH taking behavior was associated with changes in certain gene expression levels. The mRNA levels of RGS2 and RGS4 in both the VTA and NAc were positively correlated with the rate of AMPH intake. Additionally, the rate of AMPH intake was also positively correlated with RGS10 and negatively correlated with RGS17 and the short form of D2Rs mRNA level in the VTA. Although there were significant changes in the mRNA levels of RGS7 and RGS8 in the NAc, none of these measures were correlated with the rate of AMPH intake. The present study suggested that short-term AMPH self-administration produced pronounced changes in the VTA that were more associated with AMPH taking behavior than changes in the NAc.
Copyright © 2015 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  GPCR: G protein-coupled receptor; Gαi/o proteins; RGS proteins; amphetamine self-administration; dopamine D2/D3 receptors; gene expression

Mesh:

Substances:

Year:  2015        PMID: 26321241      PMCID: PMC4591251          DOI: 10.1016/j.neuroscience.2015.08.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  38 in total

1.  Distinct functions of the two isoforms of dopamine D2 receptors.

Authors:  A Usiello; J H Baik; F Rougé-Pont; R Picetti; A Dierich; M LeMeur; P V Piazza; E Borrelli
Journal:  Nature       Date:  2000-11-09       Impact factor: 49.962

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

3.  Regulator of G protein signaling Z1 (RGSZ1) interacts with Galpha i subunits and regulates Galpha i-mediated cell signaling.

Authors:  Yuren Wang; Guyu Ho; Jerry J Zhang; Bart Nieuwenhuijsen; Wade Edris; Pranab K Chanda; Kathleen H Young
Journal:  J Biol Chem       Date:  2002-10-11       Impact factor: 5.157

4.  Functional coupling of the human dopamine D2 receptor with G alpha i1, G alpha i2, G alpha i3 and G alpha o G proteins: evidence for agonist regulation of G protein selectivity.

Authors:  Lucien Gazi; Sarah A Nickolls; Philip G Strange
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 5.  Cocaine dependence: a disease of the brain's reward centers.

Authors:  C A Dackis; C P O'Brien
Journal:  J Subst Abuse Treat       Date:  2001-10

6.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex.

Authors:  N D Volkow; L Chang; G J Wang; J S Fowler; Y S Ding; M Sedler; J Logan; D Franceschi; J Gatley; R Hitzemann; A Gifford; C Wong; N Pappas
Journal:  Am J Psychiatry       Date:  2001-12       Impact factor: 18.112

7.  Dopamine D2 long receptor-deficient mice display alterations in striatum-dependent functions.

Authors:  Y Wang; R Xu; T Sasaoka; S Tonegawa; M P Kung; E B Sankoorikal
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

8.  GIPC recruits GAIP (RGS19) to attenuate dopamine D2 receptor signaling.

Authors:  Freddy Jeanneteau; Olivier Guillin; Jorge Diaz; Nathalie Griffon; Pierre Sokoloff
Journal:  Mol Biol Cell       Date:  2004-09-08       Impact factor: 4.138

9.  Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system.

Authors:  Christopher Larminie; Paul Murdock; Jean-Philippe Walhin; Malcolm Duckworth; Kendall J Blumer; Mark A Scheideler; Martine Garnier
Journal:  Brain Res Mol Brain Res       Date:  2004-03-17

10.  Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.

Authors:  F J White; R Y Wang
Journal:  J Pharmacol Exp Ther       Date:  1984-11       Impact factor: 4.030

View more
  7 in total

Review 1.  Dopamine D2 autoreceptor interactome: Targeting the receptor complex as a strategy for treatment of substance use disorder.

Authors:  Rong Chen; Mark J Ferris; Shiyu Wang
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

2.  Chronic intermittent ethanol exposure selectively alters the expression of Gα subunit isoforms and RGS subtypes in rat prefrontal cortex.

Authors:  D J Luessen; H Sun; M M McGinnis; B A McCool; R Chen
Journal:  Brain Res       Date:  2017-07-21       Impact factor: 3.252

Review 3.  Regulator of G protein signaling 10: Structure, expression and functions in cellular physiology and diseases.

Authors:  Faris Almutairi; Jae-Kyung Lee; Balázs Rada
Journal:  Cell Signal       Date:  2020-08-31       Impact factor: 4.315

Review 4.  Regulators of G Protein Signaling in Analgesia and Addiction.

Authors:  Farhana Sakloth; Claire Polizu; Feodora Bertherat; Venetia Zachariou
Journal:  Mol Pharmacol       Date:  2020-05-30       Impact factor: 4.436

5.  Prenatal Amphetamine-Induced Dopaminergic Alteration in a Gender- and Estrogen-Dependent Manner.

Authors:  C Bregonzio; M Soaje; G E Pennacchio; F E Santonja; F J Neira
Journal:  Neurochem Res       Date:  2022-02-11       Impact factor: 3.996

6.  Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice.

Authors:  Michael F Salvatore; Erin S Calipari; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2016-05-10       Impact factor: 4.418

Review 7.  Current Concepts on the Physiopathological Relevance of Dopaminergic Receptors.

Authors:  Ada Ledonne; Nicola B Mercuri
Journal:  Front Cell Neurosci       Date:  2017-02-08       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.